Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Amazon
AMZN
|
+$842M |
| 2 |
NVIDIA
NVDA
|
+$559M |
| 3 |
Microsoft
MSFT
|
+$420M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Moderna
MRNA
|
+$365M |
Top Sells
| 1 |
Baidu
BIDU
|
+$628M |
| 2 |
Tesla
TSLA
|
+$424M |
| 3 |
Palo Alto Networks
PANW
|
+$417M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$415M |
| 5 |
AT&T
T
|
+$389M |
Sector Composition
| 1 | Healthcare | 19.94% |
| 2 | Technology | 19.65% |
| 3 | Consumer Staples | 10.63% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Communication Services | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGRX
1301
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $8.43M | 0.01% |
196,879
-7,800
| -4% | -$334K |
|
1302
Cirrus Logic
CRUS
$5.91B
| $8.41M | 0.01% |
98,820
-213,000
| -68% | -$18.1M |
|
1303
China Yuchai International
CYD
$1.39B
| $8.41M | 0.01% |
524,393
-75,414
| -13% | -$1.21M |
|
1304
Commerce Bancshares
CBSH
$8B
| $8.4M | 0.01% |
136,873
+81,560
| +147% | +$5M |
|
1305
Inspire Medical Systems
INSP
$2.45B
| $8.4M | 0.01% |
+43,439
| New | +$8.4M |
|
1306
Evolent Health
EVH
$1.07B
| $8.37M | 0.01% |
396,499
+182,800
| +86% | +$3.86M |
|
|
TPC
1307
Tutor Perini Corporation
TPC
$3.29B
| $8.37M | 0.01% |
604,580
-182,900
| -23% | -$2.53M |
|
1308
Travelzoo
TZOO
$103M
| $8.34M | 0.01% |
565,191
+33,400
| +6% | +$493K |
|
1309
HUTCHMED
HCM
$2.7B
| $8.34M | 0.01% |
212,352
-9,100
| -4% | -$357K |
|
1310
Prosperity Bancshares
PB
$6.4B
| $8.33M | 0.01% |
115,972
+3,900
| +3% | +$280K |
|
|
MCFE
1311
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $8.33M | 0.01% |
+297,100
| New | +$8.33M |
|
1312
Wintrust Financial
WTFC
$9.17B
| $8.29M | 0.01% |
+109,554
| New | +$8.29M |
|
1313
Vitamin Cottage Natural Grocers
NGVC
$833M
| $8.26M | 0.01% |
769,215
+90,100
| +13% | +$968K |
|
1314
Atlanticus Holdings
ATLC
$1.02B
| $8.26M | 0.01% |
208,008
+12,400
| +6% | +$492K |
|
|
SUP
1315
DELISTED
Superior Industries International
SUP
| $8.26M | 0.01% |
957,609
-55,859
| -6% | -$482K |
|
1316
First Northwest Bancorp
FNWB
$62M
| $8.25M | 0.01% |
470,005
+33,800
| +8% | +$593K |
|
1317
Dover
DOV
$24.1B
| $8.22M | 0.01% |
+54,600
| New | +$8.22M |
|
1318
Health Catalyst
HCAT
$229M
| $8.22M | 0.01% |
148,069
-9,408
| -6% | -$522K |
|
1319
Health Care Select Sector SPDR Fund
XLV
$34.6B
| $8.21M | 0.01% |
65,200
+29,000
| +80% | +$3.65M |
|
|
CORE
1320
DELISTED
Core Mark Holding Co., Inc.
CORE
| $8.18M | 0.01% |
181,700
-54,100
| -23% | -$2.43M |
|
1321
Alto Ingredients
ALTO
$89M
| $8.17M | 0.01% |
1,337,364
-2,019,501
| -60% | -$12.3M |
|
1322
Endava
DAVA
$543M
| $8.13M | 0.01% |
71,663
| – | – |
|
1323
AptarGroup
ATR
$8.98B
| $8.07M | 0.01% |
+57,300
| New | +$8.07M |
|
1324
Natural Alternatives International
NAII
$20.8M
| $8.05M | 0.01% |
478,198
-3,000
| -0.6% | -$50.5K |
|
1325
Acme United Corp
ACU
$159M
| $8.02M | 0.01% |
179,895
+6,992
| +4% | +$312K |
|